Brought to you by 
Akzo's Organon buys Kanebo's ethical pharmaceutical unit
13 Jul 1999
Executive Summary
In an attempt to better reach the Japanese pharmaceutical market, the Organon division (contraceptives, infertility, antidepressants) of the Netherlands' Akzo Nobel NV has acquired Japanese Kanebo's ethical pharmaceutical business.
Deal Industry
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Akzo's Organon buys Kanebo's ethical pharmaceutical unit
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice